You are here

Proprietary C. Forskohlii Awarded Certification in Japan

TOKYO, JAPAN and NEW YORK, NY -- Bio Actives Japan and American Medical Holdings have announced that based on proprietary analytical and research data on Coleus forskohlii (a component of its proprietary, researched FB3® fat inhibition formula, Japan Bio Actives has obtained the High Quality Certification from Japan Health Food and Supplement Association for its FB3® Coleus Forskohlii extract. Vladimir Badmaev, MD, PhD, CEO of American Medical Holdings and formulator of FB3, commented, "This certificate was awarded after evaluation of the FB3® C. forskohlii safety data, green-solvents extraction technology and the peer review published clinical efficacy data. The regulatory evaluation process took over 1.5 years to complete and attests to high quality of the FB3® formula."

View Certificate